棘阿米巴角膜炎的诊断与治疗进展
Advances in the diagnosis and treatment of acanthamoeba keratitis.
作者信息
Clarke Benjamin, Sinha Arti, Parmar Dipak N, Sykakis Evripidis
机构信息
Department of Ophthalmology, Whipps Cross University Hospital, Whipps Cross Road, London E11 1NR, UK.
出版信息
J Ophthalmol. 2012;2012:484892. doi: 10.1155/2012/484892. Epub 2012 Dec 6.
Abstract
This paper aims to review the recent literature describing Acanthamoeba keratitis and outline current thoughts on pathogenesis, diagnosis, and treatment as well as currently emerging diagnostic and treatment modalities.
摘要
本文旨在综述近期描述棘阿米巴角膜炎的文献，并概述目前关于发病机制、诊断和治疗的观点以及当前新出现的诊断和治疗方式。
相似文献
1
Advances in the diagnosis and treatment of acanthamoeba keratitis.
J Ophthalmol. 2012;2012:484892. doi: 10.1155/2012/484892. Epub 2012 Dec 6.
2
[Amoebas of the genus acanthamoeba as an etiological factor of keratitis].
Klin Oczna. 2010;112(4-6):161-4.
3
New approach to diagnosis and treatment of Acanthamoeba keratitis--systematic review of literature.
Klin Oczna. 2012;114(4):311-6.
4
Diagnosis and management of Acanthamoeba keratitis.
Curr Opin Ophthalmol. 2006 Aug;17(4):327-31. doi: 10.1097/01.icu.0000233949.56229.7d.
5
The epidemic of Acanthamoeba keratitis: where do we stand?
Cornea. 1998 Jan;17(1):3-10. doi: 10.1097/00003226-199801000-00001.
6
Current advances in diagnostic methods of Acanthamoeba keratitis.
Chin Med J (Engl). 2014;127(17):3165-70.
7
An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment.
Parasite. 2015;22:10. doi: 10.1051/parasite/2015010. Epub 2015 Feb 18.
8
Acanthamoeba Keratitis: Current Status and Urgent Research Priorities.
Curr Med Chem. 2019;26(30):5711-5726. doi: 10.2174/0929867325666180510125633.
9
Review of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: experience of over a decade.
Indian J Ophthalmol. 2009 Jul-Aug;57(4):273-9. doi: 10.4103/0301-4738.53051.
10
Advances in the management of Acanthamoeba keratitis: A review of the literature and synthesized algorithmic approach.
Ocul Surf. 2022 Jul;25:26-36. doi: 10.1016/j.jtos.2022.04.003. Epub 2022 Apr 22.
引用本文的文献
1
The pathogenesis, risk factors, diagnosis and treatment of Acanthamoeba keratitis.
Front Med (Lausanne). 2025 Jul 24;12:1559224. doi: 10.3389/fmed.2025.1559224. eCollection 2025.
2
Acanthamoeba Keratitis Management and Prognostic Factors: A Systematic Review.
J Clin Med. 2025 Apr 7;14(7):2528. doi: 10.3390/jcm14072528.
3
Novel antibodies detect nucleocytoplasmic O-fucose in protist pathogens, cellular slime molds, and plants.
mSphere. 2025 Feb 25;10(2):e0094524. doi: 10.1128/msphere.00945-24. Epub 2025 Feb 6.
4
Prevalence of HSV Genomic Signatures Among Acanthamoeba Hosts and Contaminated Lens Cases: A Molecular and Clinical Study.
Invest Ophthalmol Vis Sci. 2025 Feb 3;66(2):4. doi: 10.1167/iovs.66.2.4.
5
Novel antibodies detect nucleocytoplasmic O-fucose in protist pathogens, cellular slime molds, and plants.
bioRxiv. 2024 Oct 22:2024.10.15.618526. doi: 10.1101/2024.10.15.618526.
6
The Anti-Amoebic Activity of a Peptidomimetic against .
Microorganisms. 2022 Nov 30;10(12):2377. doi: 10.3390/microorganisms10122377.
7
Tannic Acid-Modified Silver Nanoparticles in Conjunction with Contact Lens Solutions Are Useful for Progress against the Adhesion of spp. to Contact Lenses.
Microorganisms. 2022 May 24;10(6):1076. doi: 10.3390/microorganisms10061076.
8
In vitro anti- activity of the commercial chitosan and nano-chitosan against pathogenic genotype T4.
J Parasit Dis. 2021 Dec;45(4):921-929. doi: 10.1007/s12639-021-01380-3. Epub 2021 Mar 25.
9
Silver Nanoparticles Conjugated with Contact Lens Solutions May Reduce the Risk of Keratitis.
Pathogens. 2021 May 11;10(5):583. doi: 10.3390/pathogens10050583.
10
Early therapeutic lamellar keratoplasty for acanthamoeba keratitis followed by implantable Collamer lens for visual rehabilitation.
Middle East Afr J Ophthalmol. 2021 Jan 19;27(4):244-246. doi: 10.4103/meajo.meajo_557_20. eCollection 2020 Oct-Dec.
本文引用的文献
1
[Acanthamoeba keratitis--a rare and often late diagnosed disease].
Klin Monbl Augenheilkd. 2012 May;229(5):521-8. doi: 10.1055/s-0031-1299539. Epub 2012 May 16.
2
Corneal cross-linking as supplementary treatment option in melting keratitis: a case series.
Klin Monbl Augenheilkd. 2012 Apr;229(4):411-5. doi: 10.1055/s-0031-1299420. Epub 2012 Apr 11.
3
Detection of free-living amoebae by using multiplex quantitative PCR.
Mol Cell Probes. 2012 Jun;26(3):116-20. doi: 10.1016/j.mcp.2012.03.003. Epub 2012 Mar 17.
4
Assessment of real-time polymerase chain reaction detection of Acanthamoeba and prognosis determinants of Acanthamoeba keratitis.
Ophthalmology. 2012 Jun;119(6):1111-9. doi: 10.1016/j.ophtha.2011.12.023. Epub 2012 Mar 3.
5
Acanthamoeba keratitis in South India: a longitudinal analysis of epidemics.
Ophthalmic Epidemiol. 2012 Apr;19(2):111-5. doi: 10.3109/09286586.2011.645990. Epub 2012 Feb 24.
6
Increase in acanthamoeba keratitis may be associated with use of multipurpose contact lens solution.
BMJ. 2012 Feb 21;344:e1246. doi: 10.1136/bmj.e1246.
7
Assessing efficacy of combined riboflavin and UV-A light (365 nm) treatment of Acanthamoeba trophozoites.
Invest Ophthalmol Vis Sci. 2011 Dec 9;52(13):9333-8. doi: 10.1167/iovs.11-8382.
8
Evaluation of in vitro efficacy of combined riboflavin and ultraviolet a for Acanthamoeba isolates.
Am J Ophthalmol. 2012 Mar;153(3):399-404. doi: 10.1016/j.ajo.2011.07.025. Epub 2011 Oct 11.
9
A simple PCR condition for detection of a single cyst of Acanthamoeba species.
Parasitol Res. 2012 Apr;110(4):1569-72. doi: 10.1007/s00436-011-2662-3. Epub 2011 Oct 12.
10
Utility of real-time polymerase chain reaction in diagnosing and treating acanthamoeba keratitis.
Cornea. 2011 Nov;30(11):1233-7. doi: 10.1097/ICO.0b013e3182032196.
Zotero 插件